When a coronary stent fails, blood flow through the artery becomes restricted again, either gradually through tissue regrowth inside the stent or suddenly through a blood clot forming at the stent site. Both scenarios can cause chest pain, shortness of breath, or a full heart attack. The type of failure, how quickly it develops, and how dangerous it is vary widely.
Two Ways a Stent Can Fail
Stent failure falls into two broad categories, and they behave very differently.
In-stent restenosis is the gradual one. When a stent is placed, it causes some injury to the vessel wall. The body responds by growing new tissue inside the stent, a process called neointimal hyperplasia. Think of it like scar tissue forming inside a healing wound. Over weeks to months, this tissue can build up enough to narrow the artery again. In modern drug-eluting stents (which release medication to slow this growth), the rate of narrowing significant enough to need another procedure runs about 2% per year. Roughly half of these cases show up more than two years after the original stent was placed.
Stent thrombosis is the dangerous one. This is a blood clot that forms suddenly inside or around the stent, partially or completely blocking blood flow. Clot analysis from these events shows a mix of platelets, fibrin, and inflammatory cells. Stent thrombosis is far less common than restenosis, but it’s a medical emergency. Mortality rates range from 20% to 45%, and 50% to 70% of patients who experience it suffer a heart attack.
When Each Type of Failure Occurs
Stent thrombosis follows a well-defined timeline. Acute thrombosis happens within the first 24 hours after placement. Subacute thrombosis develops between 24 hours and one month. Late thrombosis occurs between 1 and 12 months, and very late thrombosis strikes after 12 months. The earliest events tend to relate to problems with the procedure itself or the stent’s initial contact with the vessel wall. Later events often involve incomplete healing of the tissue around the stent struts.
Restenosis develops more slowly. With bare metal stents, tissue regrowth typically peaks around 6 to 12 months. Drug-eluting stents push this timeline out further, but a separate process can take over in the long term: neoatherosclerosis. This is essentially new plaque forming inside the stent. Unlike the original atherosclerosis that took years or decades to develop, this in-stent version can form in months to years. It involves the same buildup of fatty cells and debris you’d see in a diseased artery, sometimes with internal bleeding and calcification within the new tissue.
What Stent Failure Feels Like
The symptoms depend on which type of failure is happening and how fast blood flow drops.
Stent thrombosis often hits like a sudden heart attack: crushing chest pain, shortness of breath, sweating, nausea, and pain radiating to the arm, jaw, or back. Because the artery can go from open to completely blocked in minutes, there’s little warning. This is a 911 situation.
Restenosis is more likely to creep up. You might notice the return of symptoms you had before the stent was placed: chest tightness or pressure during exertion, shortness of breath with activity, or fatigue that worsens over weeks. That said, about two-thirds of restenosis cases still show up as unstable angina or a heart attack, so the line between “gradual” and “urgent” isn’t always clear. If chest symptoms you thought were resolved start coming back, that warrants prompt attention.
In rare cases, people develop allergic-type reactions to stent materials, particularly with some drug-eluting stents. Symptoms can include rash, hives, itching, joint or muscle pain, and difficulty breathing.
What Raises the Risk of Failure
The single biggest risk factor for stent thrombosis is stopping or skipping anti-clotting medications. After a stent is placed, you’re prescribed dual antiplatelet therapy (typically aspirin plus a second blood thinner) to prevent clots from forming while the vessel heals around the stent. Stopping these medications early, whether because of cost, side effects, or an upcoming surgery, dramatically increases clot risk.
Other factors that raise the overall odds of stent failure include diabetes, continued smoking, kidney disease, and the complexity of the original blockage. Stents placed in very small arteries, at branch points, or across long segments of disease are more prone to problems. Incomplete expansion of the stent during placement, where the metal doesn’t fully press against the vessel wall, also creates conditions where clots can form or tissue can grow unevenly.
How Doctors Identify the Problem
If stent failure is suspected, the first step is usually a coronary angiogram, where dye is injected into the arteries and X-ray imaging reveals any blockages. This shows whether the stent is narrowed or clotted, but it doesn’t always explain why.
For a closer look, doctors can thread specialized imaging catheters directly into the artery. Intravascular ultrasound (IVUS) uses sound waves to create cross-sectional images of the vessel, showing how much tissue has grown inside the stent and whether the stent is properly expanded against the wall. It’s especially useful for detecting underexpansion, but it struggles to image through heavy calcium and isn’t great at spotting clots. Optical coherence tomography (OCT) uses near-infrared light and provides much higher resolution, making it the better tool for seeing fine details like how well tissue has healed over the stent struts, thin layers of clot, or cracks in plaque. Together, these tools help determine whether the failure was caused by tissue overgrowth, clot formation, mechanical problems with the stent, or new plaque development.
What Happens Next
Treatment depends on the type and severity of the failure.
For stent thrombosis, the response is urgent. The goal is to reopen the artery as fast as possible, typically through an emergency catheterization procedure to remove or dissolve the clot and restore flow. This mirrors the treatment for any acute heart attack. Doctors will also investigate why the clot formed, whether that’s medication noncompliance, a mechanical issue with the stent, or an underlying condition.
For in-stent restenosis, the options are more measured. The three main approaches are:
- Drug-coated balloon angioplasty: A balloon coated with anti-growth medication is inflated inside the stent. It delivers the drug directly to the vessel wall without adding another layer of metal. This has become a leading option for treating restenosis.
- Repeat stenting: A new drug-eluting stent is placed inside the old one. This works well in many cases, though it does reduce the artery’s internal diameter slightly with each additional stent layer.
- Plain balloon angioplasty: Simply inflating a balloon to push back the excess tissue. Less effective long-term than drug-coated options, but sometimes appropriate depending on the situation.
When catheter-based fixes aren’t viable, or when the problem keeps recurring, coronary bypass surgery becomes the alternative. This is more common when multiple stents have failed, when the anatomy is too complex for another catheter procedure, or when there’s hemodynamic instability (blood pressure crashing, severe ongoing chest pain with ECG changes, or a punctured artery). Bypass surgery reroutes blood flow around the blocked segment entirely using a vessel grafted from elsewhere in the body.
The choice between these options depends on factors specific to each case: how many times the stent has re-narrowed, the length and location of the blockage, how much heart muscle is at risk, and the patient’s overall health. For most people experiencing their first episode of restenosis, a catheter-based approach is the starting point, with surgery held in reserve for more complex or recurrent failures.